Research into the control of cholesterol levels and preventing cardiovascular risk is constantly under development and there are many different lines of research to reduce the cardiovascular complications and improve patient quality of life.
Some of the current lines of research are:
Nutritional research. A suitable diet can reduce cholesterol levels or mitigate its damaging effects on the arteries.
Real-life safety of drugs. Once medicines have been released onto the market, follow-up and monitoring of individuals under treatment is an essential part of epidemiological research to consolidate the safety of drugs. It should not be forgotten that treatments for high cholesterol must be taken for many years, so this represents an important issue.
New drugs. The search for safer, more specific, easier to dose drugs with new mechanisms of action that have a longer duration is also an area of constant development. Drugs that inhibit the production of certain proteins at a genetic level, potential vaccines with a sustained effect and drugs that reduce other harmful cholesterols – such as lipoprotein (a) – or increase the level of good (HDL) cholesterol are some of the new possibilities in different stages of research.
Sorry this content wasn't helpful to you. Send us your comment and we will take it into account to continue improving.
Thanks for your help!
An error has occurred and we were unable to send your opinion, please try again later.
Substantiated information by:
Antonio J. Amor FernandezEndocrinologistEndocrinology and Dietetics Department
Daniel Zambón RadosMedical InternistEndocrinology Department
Emilio Ortega Martinez de VictoriaEndocrinologistEndocrinology and Dietetics Department
Gemma Yago EstebanNurseEndocrinology and Dietetics Department
Violeta Moize ArconeDietitianEndocrinology and Dietetics Department
Published: 2 October 2018
Updated: 2 October 2018
The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.
Subscribe
Receive the latest updates related to this content.
Thank you for subscribing!
If this is the first time you subscribe you will receive a confirmation email, check your inbox
An error occurred and we were unable to send your data, please try again later.